Evidence map›Paper›PMID 31937894›Full record

ArticleLeukemia2020

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.

H Pfeifer, G Cazzaniga, V H J van der Velden, J M Cayuela, B Schäfer, O Spinelli, S Akiki, S Avigad, I Bendit, K Borg and 29 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

H PfeiferDepartment of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany. h.pfeifer@em.uni-frankfurt.de.
G CazzanigaPediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.
V H J van der VeldenDepartment of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
J M CayuelaHematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France.
B SchäferKinderspital Zurich, Onkologie Diagnostik Labor, Zurich, Switzerland.
O SpinelliHematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.ORCID http://orcid.org/0000-0003-0374-1536
S AkikiRegional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
S AvigadPediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
I BenditDivision of Hematology and Hemotherapy, Medical School, University of Sao Paulo, Sao Paulo, Brazil.
K BorgDepartment of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
H CavéDepartment of Genetic Biochemistry, Hopital Robert Debre, Paris, France.
L EliaDepartment of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy.
S C ReshmiInstitute for Genomic Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA.
G GerrardImperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-4614-227X
S HayetteLaboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Benite, Lyon, France.
M HermansonDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
A JuhDivision of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore.
T JurcekDepartment of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
M C ChillónDepartment of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain.
C HomburgDepartment of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands.
G MartinelliIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
V KairistoTYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland.
T LangeAbteilung fur Hamatologie und internistische Onkologie, Universitat Leipzig, Leipzig, Germany.
T LionChildrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria.
M C MuellerIII. Medizinische Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany.
F PaneAzienda Ospedaliera Universitaria Federico II di Napoli Universita, Naples, Italy.
L RaiDepartment of Hematology, Royal Free Campus, University College London, London, United Kingdom.
C Damm-WelkDepartment of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany.
T SachaHematology Department, Jagiellonain University Krakow, Krakow, Poland.
S SchnittgerMLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany.
T TouloumenidouHematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
H ValerhaugenDepartment of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
P VandenbergheCenter for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
J ZunaCLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic.
H ServeDepartment of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
E HerrmannInstitut fur Biostatistik und Mathematische Modellierung, Goethe Universitat, Frankfurt, Germany.
S MarkovicDepartment of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
J J M van Dongen *Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
O G Ottmann *School of Medicine, Division of Cancer and Hematology, Cardiff University, Cardiff, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31937894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.